Drexel University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Drexel University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12408
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Drexel University (Drexel) is a research university which provides educational degrees and research programs. The university offers courses for undergraduate courses, graduate and professional courses, adult education programs, colleges and schools, libraries and online training services. It also provides professional degree programs in architecture, science, chemical engineering, civil engineering, construction management, culinary science, nutrition and food, information systems and sports management. Drexel University also conducts research programs. The university operates through its campuses in various cities throughout the US. Drexel is headquartered in Philadelphia, Pennsylvania, the US.

Drexel University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Drexel University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Drexel University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Drexel University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Drexel University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Drexel University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Drexel University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
CytoDyn Amends Research Agreement with Drexel University College of Medicine 10
Licensing Agreements 11
Oncore Biopharma Enters into Licensing Agreement with Baruch S. Blumberg Institute and Drexel University 11
Oncore Biopharma Enters into Licensing Agreement with Baruch S. Blumberg Institute and Drexel University 12
OnCore Biopharma Enters into Licensing Agreement with Drexel University 13
Drexel University – Key Competitors 14
Drexel University – Key Employees 15
Drexel University – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Strategy And Business Planning 17
Apr 16, 2018: Geisinger expands access to clinical trials through consortium with five other health systems 17
Government and Public Interest 19
Jun 21, 2018: Medicaid Expansion Under the ACA Increased Low-Income Patient Access to Kidney Transplants 19
Apr 16, 2018: Drexel Joins Regional Health Systems to Expand Access to Clinical Trials 21
Apr 16, 2018: Six Health Systems form Consortium to Expand Access to Clinical Trials, Bringing Access to Clinical Trials Closer to Home 22
Oct 05, 2017: Multivitamin Use During Pregnancy Linked to Lower Risk of Autism With Intellectual Disability 23
Sep 07, 2017: NIH awards nearly $100 million for Autism Centers of Excellence program 24
Jun 06, 2017: Study Identifies an Enzyme Inhibitor to Treat Gulf War Illness Symptoms 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Drexel University, Pharmaceuticals & Healthcare, Key Facts 2
Drexel University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Drexel University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Drexel University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Drexel University, Deals By Therapy Area, 2012 to YTD 2018 8
Drexel University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CytoDyn Amends Research Agreement with Drexel University College of Medicine 10
Oncore Biopharma Enters into Licensing Agreement with Baruch S. Blumberg Institute and Drexel University 11
Oncore Biopharma Enters into Licensing Agreement with Baruch S. Blumberg Institute and Drexel University 12
OnCore Biopharma Enters into Licensing Agreement with Drexel University 13
Drexel University, Key Competitors 14
Drexel University, Key Employees 15
Drexel University, Other Locations 16
Drexel University, Subsidiaries 16

List of Figures
Drexel University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Drexel University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Drexel University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Drexel University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Drexel University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Drexel University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Drexel University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Drexel University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Drexel University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MeVis Medical Solutions AG (M3V)-医療機器分野:企業M&A・提携分析
    Summary MeVis Medical Solutions AG (MMS AG) is a medical technology company. It develops and offers medical imaging solutions for digital computer-aided medical imaging. The software solutions are used in screening, diagnostics, therapy and intervention planning for breast, lung, colon, and prostate …
  • Crossject SA (ALCJ):医療機器:M&Aディール及び事業提携情報
    Summary Crossject SA (Crossject) is a medical device company that develops injection systems. The company’s pipeline products include sumatriptan for the treatment of migraines and cluster headaches; adrenaline for the treatment of anaphylactic shock; hydrocortisone for the treatment of acute adrena …
  • Ambu AS (AMBU B):企業の財務・戦略的SWOT分析
    Ambu AS (AMBU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Xellia Pharmaceuticals ApS:製薬・医療:M&Aディール及び事業提携情報
    Summary Xellia Pharmaceuticals ApS (Xellia), a subsidiary of Novo A/S is a healthcare products provider that offers fermented and semi-synthetic APIs and injectable finished dosage forms. The company offers strain and fermentation development with bacteria and fungi. It provides injectable products …
  • Robins & Morton LLC:企業の戦略・SWOT・財務情報
    Robins & Morton LLC - Strategy, SWOT and Corporate Finance Report Summary Robins & Morton LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Great Eastern Holdings Limited (G07):企業の財務・戦略的SWOT分析
    Great Eastern Holdings Limited (G07) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • BlackPearl Resources Inc (PXX):石油・ガス:M&Aディール及び事業提携情報
    Summary BlackPearl Resources Inc (BlackPearl), formerly Pearl Exploration and Production Ltd, is an oil and gas company that explores, develops and produces heavy oil and oil sands assets in western Canada. The company's properties include Blackrod property, Onion Lake property and Mooney property i …
  • juwi AG:企業の戦略的SWOT分析
    juwi AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Plasticell Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Plasticell Ltd (Plasticell) is a biotechnology company that develops therapies derived from research using its combinatorial cell culture technology. The company offers therapeutic programs such as expansion of hematopoietic stem cells from bone marrow and cord blood, platelets and immune ce …
  • University of California Los Angeles-医療機器分野:企業M&A・提携分析
    Summary University of California Los Angeles (UCLA) a subsidiary of University of California is an educational service provider that offers undergraduate education, graduate, professional education and continuing education. The university’s services include support services, campus services, graduat …
  • BOOM Logistics Ltd (BOL):企業の財務・戦略的SWOT分析
    BOOM Logistics Ltd (BOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • BioDelivery Sciences International Inc (BDSI):企業の財務・戦略的SWOT分析
    BioDelivery Sciences International Inc (BDSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Kimal plc-医療機器分野:企業M&A・提携分析
    Summary Kimal plc (Kimal) is a medical equipment company that develops, manufactures and markets customised procedure packs and vascular access devices. The company’s products include soft tissue biopsy needles, bone marrow biopsy needles, catheter accessories, catheter lock solution, closure device …
  • Umecrine Cognition AB-製薬・医療分野:企業M&A・提携分析
    Summary Umecrine Cognition AB (Umecrine), a subsidiary of Umecrine AB is a developer of treatments for neurological disorders in the central nervous system. The company develops pharmaceuticals for the treatment of acute life-threatening hepatic encephalopathy (HE) and long-term maintenance in minim …
  • Tallgrass Energy Partners, LP (TEP)-石油・ガス分野:企業M&A・提携分析
    Summary Tallgrass Energy Partners, LP (Tallgrass Energy) is a midstream oil and gas company. It owns, operates, acquires and develops midstream energy assets in North America. The company offers natural gas transportation and storage services through its pipeline and natural gas processing assets to …
  • Astute Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Astute Medical Inc (Astute Medical) is a healthcare service provider that provides diagnostic products. The company offers biomarker products such as nephro check test and astute meter. Its products are used in the field of identifying and validating biomarkers of acute kidney injury through …
  • Huron Consulting Group Inc
    Huron Consulting Group Inc - Strategy, SWOT and Corporate Finance Report Summary Huron Consulting Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Monadelphous Group Ltd (MND):企業の財務・戦略的SWOT分析
    Monadelphous Group Ltd (MND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Inova Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Inova Diagnostics Inc (Inova), a subsidiary of Werfen Life Group SAU is a medical device company that develops and commercializes new autoimmune technologies and diagnostic markers. The company's diagnostic reagent products include QUANTA Flash used for semi-quantitative determination of aut …
  • Royal Dutch Shell Plc (RDSA):電力:M&Aディール及び事業提携情報
    Summary Royal Dutch Shell plc (Shell) is an integrated oil and gas company. The company explores for and produces oil and gas from conventional fields and sources such as tight rock, shale and coal formations. Its refining and petrochemical complexes across the world add value to its upstream produc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆